Cord blood has a track record of success, and cord tissue stem cells are also making great progress as an important medical resource. Mesenchymal stem cells from cord tissue have multiple properties that make them beneficial to medicine.

Cord tissue stem cells are currently being researched to treat the following:

  • Alzheimer’s
    (1 in 3 seniors die with Alzheimer’s or other form of dementia)
  • Heart Disease
    (Leading cause of death in the United States)
  • Type 1 Diabetes
    (13,000 children diagnosed with Type 1 diabetes every year)
  • Arthritis
    (1 in 2 people may develop knee problems by age 85)
  • Stroke
    (795,000 people have a stroke every year)

Save both for more potential.

One of the most beneficial traits of Mesenchymal stem cells is their ability to avoid immune systems. Whereas cord blood requires HLA matching, cord tissue does not. This means that, theoretically, the Mesenchymal stem cells in your baby’s cord tissue could potentially be used not only for his or her siblings, but in you or your parents as well. This alongside the cell’s potential ability to treat age-related diseases makes it an even more precious resource.

Download our infographic to learn more about
the differences between Cord Blood and Cord Tissue.